Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
some selling on scrk and trab, wonder if thats messalass and the roach
material statments are minium with stocks, ctno being shut down would be a very important piece of news. i certainly would not have been adding or buying. if he has been giving shares to insiders after a cease and desist order and suspension, especialy if they have dumped all of them. how many laws would of been broken. moving ctno from 120 wallstreet to carson city nevada, is that somthing to do with knowledge of a sec investigation headed their way?
if the roach and cm are found guilty we would be intitled to his personal assetts to satisfy our investment. all we would be intitled to would be our initial investment.
you can bet he's scrambling to hide assets and monies if he has any.
this guy is definetly knee deep in this, i wonder if he claimed that on his taxes?
Forman was an officer and/or director of two of the Fund portfolio companies, and a Fund investor. In November 2008, the fund lent $50,000 to Forman. The loan to Forman also went unpaid, and Respondents again took no action to collect the $50,000 the Fund is owed.
i think they were trying to create a paper trail that couldn't be followed, or so they thought. hickels into this right up to his extremely fat azz.
Hickel, a Fund investor and the Chairman of the Advisory Committee for LeadDog, was also an officer or director of five of the six public companies in the Fund’s portfolio, as well as an officer or director of several other private companies in which Respondent LeadDog directed fund investments. Hickel was also an employee of the broker-dealer controlled by Respondent Messalas, Brookstone. In November 2008, the Fund lent $20,000 to an entity controlled by Hickel, and LeadDog recorded the loan as an asset of the Fund. When Hickel failed to satisfy the loan and the note went into default, the Respondents took no action to collect the loan or otherwise protect the Fund’s interests.
billian, that's why i posted that, is that us (capital markets) or are we the carlton companies? if it is ctno we all have the right to seek monies from his and laroaches personal assetts as investor A is doing.
i'm with you there, maybe investor A will get ctno as part of a settlement. i bet cm and the roach are trying to get their hands on any cash they can during this investigation, it may be a very long spell before the can come up with another scam to bleed investors..imho
i always wondered why mr. messalas never responded to any emails or phone calls, he has been hiding all this time hoping to stay under the radar. how about larocco and esq. to boot, never expected him to be a thief if the charges are true. will this become a crimal court ordeal if the sec is not satisfied with their responses. also will their personal assets be protected under incorporated laws, does that become irrelevant if their stealing?
the following pasty was from the sec charges, how come we didn't hear about this?
Messalas directly or indirectly was involved in at least one NASD customer arbitration asserting securities law violations against him, and at least one broker-dealer he controlled, Carlton Capital Markets, Inc. (“Carlton Capital”), had been repeatedly fined, censured and, ultimately, expelled by FINRA. Respondents also deliberately concealed these material facts from Investor A, in response to his direct written questions on the subject.
Messalas has a history of customer and FINRA complaints. In August 2005, FINRA censured and fined the broker-dealer that Messalas owned and controlled, Carlton Capital, $10,000 for its failure to comply with the Bank Secrecy Act of 1970. Messalas owned 100% of LD Partners through September 2008, and 60% thereafter. Messalas is a 60% owner of LD 4 Markets. LaRocco, age 53, resides in New Canaan, Connecticut. Since September 2008, LaRocco has been a managing member, general counsel, and a 40% owner of LeadDog. LaRocco is not registered with the Commission in any capacity.
i foregot about korsair holdings, another vehicle to squeeze cash out of unsuspecting hands. http://www.korsairholdings.com/en/management
if the sec does their homework i think the following companies will be suspect: ueec, trab, scrk, bicb and i'm sure theirs more. looks like kelly t.hickel, phillip foreman, jan e. chason and boris rubiznevsky are all into this, i wonder how deep the rabbit hole goes? are their more companies listed at the 120 wall street addy. my suspicions are conjecture, it's all based on my opinion. if i'm wrong i'm wrong. if i'm right i sure hope all of them get whats coming to them. they seem to be out strictly for themselves.
does anyone have that chinese pr and chris messalas's denial saved? if you do could you email it to me at wallwizz@yahoo.com or post it. i would like to forward those to the sec. it may be the only action we'll get a shot at.
my bad, i didn't realize it was a half day of trading, your right typical mm move at end of trading day. regardless, i wonder how the turkey taste at the messalas and larocco homes....crow!
bicb hasn't went to zero bid yet, .01 x .02
ueec and msto now 0 bid! looks like mms are paying attention, or the sec is advising them.
ctno just went to .0003 x 0319, knew that was coming. trab just had a 50k dump, my guess messalas and the roach will try to dump as much as they can to salvage some sort of lifestyle.
dhana, i have always contended chris was behind that pr, now it makes sense why ctno has never been updated. as i said before to many skeletons in the closet, it's always been about his hedge funds and extracting money from unsuspecting certified investors. the best part of that sec charges is the loans and not being collected. i sure hope they check out hickels bank records on that 50k, was it split 3 ways. theres always a money trail, just have to follow it. if in fact it was split 3 ways and chris and laroch didn't declare , is that laundering or tax evasion or both?
i don't know for sure and would it even be possible considering the sec investigation. i figure this hasn't had any financial updates, if it had chris would of had to acknowledge past and present litigations/sec sensures and so on. we may very well be between a rock and a hard spot. the only solice i get from this would be larocco barred and messalas unable to be part of any public companies. chris at the age of 45 and never having to earn and honest living, he's in for a schooling of hard knocks. kiss those diamonds and fancy cars goodbye, it's hard to have any sympathy for either chris or the roach. looking back on the chinese phony pr, does anyone think chris might have been behind it and had other over the counter individuals selling into the run? i remeber he took his good ole time putting out a denial about the merger pr, plenty of time for others to unload on his behalf. now that the sec is involved chris messalas and la roach's credibility is certainly in question. does anyone else think chris was above masterminding a deceptive pr before reversing the stock?
if the sec knows about CTNO, this could be somthing they can liquidate. by the way investor A is the investor that gave chris messalas and joseph larocco 500k the other 1 million 7 hundred k was eleven other investors. i have a feeling the more this is investigated the two of them will dig deeper holes for themselves. also, there are alot more companies that may come under scrutiny such as all the companies listed at the wall street address.
To date, Respondents have refused to liquidate anything other than a small portion of Investor A’s investment in the Fund.
i wonder how long messalas has known these sec charges were coming his way? this is why he doesn't take any calls, all they have been doing is passing the money around, sounds like foreman and hickel will be implicated in this. is there any honesty left on wall street, sure doesn't seem that way. the loans that were given to hickel and foreman and never paid back, is it possible all they did was split the moneys up between them? i sure hope the sec looks at that very closely.
now the Carlton companies inc. the following pretty much explains why we haven't seen financials, messalas would of had to of shown these problems in the filings:
6. Messalas, age 45, resides in Staten Island, New York. Messalas owned 100% of LeadDog through September 2008, and 60% thereafter when LaRocco purchased a 40% interest, and he was primarily responsible both for LeadDog’s investment decisions on behalf of the Fund and for determining the fair value of the Fund’s holdings. From 1996 to 2009, Messalas was a registered representative of nine successive broker-dealers. During the Relevant Period alone, he was a registered representative of three successive broker-dealers, and held Series 7, 24 and 63 securities licenses. Messalas has a history of customer and FINRA complaints. In November 2004, Messalas entered into a $45,000 settlement with a customer whose NASD arbitration complaint alleged that Messalas caused $1.6 million in losses as a result of misrepresentations, omissions, churning and suitability violations. In August 2005, FINRA censured and fined the broker-dealer that Messalas owned and controlled, Carlton Capital, $10,000 for its failure to comply with the Bank Secrecy Act of 1970. In November 2008, FINRA censured and fined Carlton Capital $40,000 for improperly providing registered representatives with access to unrecorded telephone lines and permitting representatives to accept customer orders on unrecorded lines. In January 2009, FINRA expelled Carlton Capital for its failure to pay the $40,000. When that broker-dealer closed, Messalas opened a branch office of Brookstone Securities, Inc. (“Brookstone”) at the same location, which he controlled. Messalas owned 100% of LD Partners through September 2008, and 60% thereafter. Messalas is a 60% owner of LD
4
Markets. At all times during the Relevant Period Messalas was an investment adviser within the meaning of the Advisers Act.
7. LaRocco, age 53, resides in New Canaan, Connecticut. Since September 2008, LaRocco has been a managing member, general counsel, and a 40% owner of LeadDog. LaRocco is an attorney, licensed in Connecticut, whose legal practice included advising hedge funds on compliance with federal securities laws and regulations. LaRocco was responsible for all legal functions on behalf of the Fund, and most administrative functions. LaRocco has practiced before the Commission, representing clients in several Commission investigations. LaRocco is not registered with the Commission in any capacity. LaRocco purchased a 40% interest in LD Partners in September 2008 from Messalas, and also owns 40% of LD Markets.
I'm glad i didn't waste my money on that add, i was a little aprehenceive about a law suit. do you think ctno address change had anything to do with this latest sec charges? i would think that answer is a no brainer, he's trying to hide what little he has. what can be the worst thing to happen to the roach and messalas?
The quarterly says unaudited, i don't think they will take a chance on any misinformation.
I HAVE NO IDEA WHERE ARTS IS, WHERE IS TSRR!!
PBHG FINANCIALS POSTED 11-15-11
http://www.otcmarkets.com/financialReportViewer?symbol=PBHG&id=65398
seems ed has posted financials for pbhg today. maybe there is hope for tsrr.
http://www.otcmarkets.com/financialReportViewer?symbol=PBHG&id=65398
i am so discouraged over this companies snail pace on everything it seems to be doing. i read the letter that ed put out stating tsrr is lucky to be adopted by him, if not this would still be dormant and grey? am i missing somthing, tsrr is still dormant and grey!
NEWS
SUNRISE, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) a leader in the field of stem cell therapy for the treatment of damaged hearts, today announced that it entered into a $3M standby equity purchase agreement, previously announced in October.
The Florida investor has agreed to purchase up to $3M of BHRT common stock upon request, subject to certain conditions, including the registration of those shares on a registration statement that has been declared effective by the SEC.
Bioheart plans to use the proceeds of each of the draws to continue its FDA approved trials.
Bioheart's President and CEO, Mike Tomas said, "This money gets us that much closer to our end goal of going to market and turning our clinical data into lifesaving procedures. Bioheart has been enrolling patients in clinical trials using stem cells for over 10 years. We are fortunate to have supportive funding partners who allow us to continue development of these products."
Further details of the financing terms will be disclosed in the Company's filing with the SEC on Form 8-K.
About Bioheart, Inc.
Bioheart is committed to the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Our leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
Specific to biotechnology, we are focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Our leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
For more information on Bioheart, visit http://www.bioheartinc.com.
Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or "continue" or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled "Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2010, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.
NEWS, THEY HAVE MONEY!
Bioheart Enters Into $3,000,000 Financing Agreement
WHAT WOULD BE THE ODDS IN THAT ACTUALLY HAPPENING TODAY, ON TIME!?
hows level 2 looking, do we have a heavy accumulation on the bid side. just wondering whats holding this back.
this is great news, dated nov. 14, 2011
SUNRISE, Fla., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (OTCBB:BHRT.OB - News) today released a short clip from the American Investor Documentary. William P. Murphy Jr., MD talks about the unrealized opportunities with the Bioheart technology and the strong management team leading the efforts.
Dr. Murphy has served as a member of Bioheart's Board of Directors since June 2003 and is currently serving as the Chairman of the Board. Murphy, son of a Nobel Prize winner in medicine, is a pioneer in applying engineering to medicine. His many successful medical devices include disposable medical procedure trays, blood bags, physiologic cardiac pacemakers, angiographic injectors, and hollow fiber artificial kidneys. In 1957, he founded Medical Development Corporation in his garage. Soon after, it became Cordis Corporation, which today, as a subsidiary of Johnson & Johnson, focuses on developing medical instrumentation. Murphy also founded Small Parts, Inc., acquired by Amazon.com, which provides small and large quantities of specialized materials and tools to engineers. He is the recipient of a number of honors, including the prestigious induction into the National Inventors Hall of Fame.
Bioheart's president and CEO, Mike Tomas said, "Having the endorsement and continued support from a visionary in the field like Dr. Murphy is truly an honor. Bioheart's stem cell technology could revolutionize the field of medicine for cardiac patients."
Click here to view Dr. Murphy on The American Investor
why no news, it's like this where ever chris messalas and joe larcco are involved you'll be lucky to get any updates let alone news! take a look at the connection here, it think it's all about warrants, loans, strickly a way to ballance the end of the year tax sheets. imho
same same on tsrr, still grey as he!!. have even tried the silence approacch to no avail, is anything to come of tsrr and pbhg?
i think eddie better be there as ordered, any reason to not be there has to be submited on or before nov. 12, 2011 and that also applies to discovery motions.
anyone have level 2, how many sells are stacked up?
major dump today
diluting normally takes place thru a pr blitz, we have seen that in the past. i think the moneys they're looking for will be thru airspeed, not toxic financing. the downward pressure we seem to be experiencing is as i said, someone is eligable for cheap shares at a given price based on daily trading activity.
i almsot get the feeling some group is trying to keep this down, they may have options to buy at so many days low! small trades keep hitting the bid after the ask is slapped. that also tells me somthing good is in the very near future for bhrt, i think it will have alot to do with the pr i posted.